The average price per insulin unit hit a 10-year low in 2024, largely driven by federal actions and voluntary price cuts from drugmakers, according to a Jan. 15 GoodRx report. GoodRx analyzed the ...
ORLANDO -- Most adults with type 1 diabetes switching from an insulin pump or multiple daily injections to inhaled insulin (Afrezza) needed to increase their dose of the inhaled product to achieve ...
FILE PHOTO: Picture illustration of a UnitedHealth Group health insurance card in a wallet (Reuters) -UnitedHealth's pharmacy benefit manager unit said on Thursday it was adding eight insulin products ...
The FINANCIAL — Eli Lilly and Company and Boehringer Ingelheim Pharmaceuticals, Inc. announced on December 15 that BASAGLAR (insulin glargine injection 100 units/mL) is available by prescription in ...
Tresiba is a long-acting insulin prescribed to manage blood sugar levels in adults and children over 1 year old with type 1 and type 2 diabetes. The appropriate Tresiba dosage varies depending on ...
Patients treated with semaglutide 7.2 mg achieved a 20.7% weight loss after 72 weeks compared with a reduction of 17.5% with semaglutide 2.4 mg (Wegovy) and 2.4% with placebo, results from the phase ...
Am J Health Syst Pharm. 2005;62(21):2260-2264. Verify that the patient is receiving some source of exogenous glucose before initiating infusion (e.g., total parenteral nutrition [TPN], i.v. fluids ...
Nov 9 (Reuters) - UnitedHealth's (UNH.N), opens new tab pharmacy benefit manager unit said on Thursday it was adding eight insulin products to its reimbursement list that would limit out-of-pocket ...
The protocol was evaluated for the first 30 patients. Data were collected from September 2003 to August 2004. When a patient was started on the protocol, the pharmacy clinical coordinator and the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results